Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
34.6M
-
Shares change
-
+35.7K
-
Total reported value, excl. options
-
$88.5M
-
Value change
-
+$873K
-
Put/Call ratio
-
0.63
-
Number of buys
-
44
-
Number of sells
-
-20
-
Price
-
$2.56
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q3 2016
90 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q3 2016.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.6M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (7.01M shares), VANGUARD GROUP INC (3.84M shares), NATIXIS (3.15M shares), JPMORGAN CHASE & CO (3.01M shares), BlackRock Institutional Trust Company, N.A. (2.47M shares), BlackRock Fund Advisors (2.45M shares), Broadfin Capital, LLC (2.43M shares), STATE STREET CORP (1.39M shares), Palo Alto Investors, LLC (1.26M shares), and NORTHERN TRUST CORP (984K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.